-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Downgrades Insulet to Neutral, Lowers Price Target to $230

Benzinga·04/07/2026 12:56:50
Listen to the news
Citigroup analyst Joanne Wuensch downgrades Insulet (NASDAQ:PODD) from Buy to Neutral and lowers the price target from $338 to $230.